Filing Details
- Accession Number:
- 0001140361-17-012886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-21 21:03:05
- Reporting Period:
- 2017-03-17
- Filing Date:
- 2017-03-21
- Accepted Time:
- 2017-03-21 21:03:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1613498 | Jon Snodgres | C/O Repligen Corporation 41 Seyon St, Bldg 1, Ste 100 Waltham MA 02453 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-17 | 1,909 | $34.91 | 23,789 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-17 | 4,000 | $24.50 | 27,789 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-17 | 4,000 | $0.00 | 4,000 | $24.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,000 | 2024-07-14 | No | 4 | M | Direct |
Footnotes
- 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.
Billionaire Hedge Funds
